-transparent.png){kind=logo}
The kinetics of ethyl loflazepate were studied in patients with various degrees of renal failure. A strong correlation was noted between urinary excretion of metabolite loflazepate and creatinine clearance. In contrast, elimination half-life and total plasma clearance of the sum of loflazepate + descarboxyloflazepate seemed to be independent of the degree of renal impairment. These results indicate the absence of a risk of accumulation of the 2 main and active metabolites of ethyl loflazepate in patients with renal failure.
Related Publications
B B Ba, and
A Iliadis, and
A Durand, and
Y Berger, and
J Necciari, and
J P Cano
March 1993,
No to hattatsu = Brain and development,
B B Ba, and
A Iliadis, and
A Durand, and
Y Berger, and
J Necciari, and
J P Cano
January 1985,
Arzneimittel-Forschung,
B B Ba, and
A Iliadis, and
A Durand, and
Y Berger, and
J Necciari, and
J P Cano
October 2011,
Journal of child neurology,
B B Ba, and
A Iliadis, and
A Durand, and
Y Berger, and
J Necciari, and
J P Cano
February 1987,
British journal of clinical pharmacology,
B B Ba, and
A Iliadis, and
A Durand, and
Y Berger, and
J Necciari, and
J P Cano
July 1982,
The American journal of medicine,
B B Ba, and
A Iliadis, and
A Durand, and
Y Berger, and
J Necciari, and
J P Cano
June 1982,
British journal of clinical pharmacology,
B B Ba, and
A Iliadis, and
A Durand, and
Y Berger, and
J Necciari, and
J P Cano
June 1988,
Methods and findings in experimental and clinical pharmacology,
B B Ba, and
A Iliadis, and
A Durand, and
Y Berger, and
J Necciari, and
J P Cano
January 1988,
The Journal of antimicrobial chemotherapy,
B B Ba, and
A Iliadis, and
A Durand, and
Y Berger, and
J Necciari, and
J P Cano
November 1985,
British journal of anaesthesia,
B B Ba, and
A Iliadis, and
A Durand, and
Y Berger, and
J Necciari, and
J P Cano
November 1983,
Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
